Company Profile
Bluejay Diagnostics Stock Price, News & Analysis
- Ticker:
- BJDX
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Bluejay Diagnostics is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles.
Stock performance
3.88 USD (+0.52%)
Close
Last updated: June 23, 2026 at 00:00
4.01M USD
Market cap
Why the stock is moving
BJDX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Bluejay Diagnostics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Bluejay Diagnostics is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles.
Business Model Characteristics
Bluejay Diagnostics is a commercial-tools story where install base, recurring demand, and product adoption drive the narrative more than one-off clinical events.
Position Within the Biotechnology Landscape
Compared with therapeutic biotech names, Bluejay Diagnostics sits on a different part of the landscape where utilization, customer demand, and product refresh tend to matter more than binary FDA events.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Source: Bluejay Diagnostics
- 03
Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership
Source: Bluejay Diagnostics
- 04
Bluejay Diagnostics Provides First Quarter 2026 Corporate Update
Source: Bluejay Diagnostics
- 05
Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Source: Bluejay Diagnostics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Bluejay Diagnostics (BJDX)?
Bluejay Diagnostics (BJDX) most recently closed at 3.88 USD, a +0.52% move versus the previous session.
What is the market cap of Bluejay Diagnostics (BJDX)?
Bluejay Diagnostics currently has a market capitalization of 4.01M USD on BioPharmSignal.
What does Bluejay Diagnostics do?
Bluejay Diagnostics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
On which exchange is BJDX stock listed?
Bluejay Diagnostics (BJDX) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Bluejay Diagnostics is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles., Biotechnology.
What is Bluejay?
Bluejay Diagnostics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
Which conditions is Bluejay Diagnostics targeting with Bluejay?
Bluejay Diagnostics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.
What is Diagnostics?
Bluejay Diagnostics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.